PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Rising Incidence of Cancer Promotes Uptake of Biopsy Devices Across Europe - The dramatic increase in the rate of cancer, coupled with the need for early detection, is driving the worldwide demand for biopsy devices
Rising Incidence of Cancer Promotes Uptake of Biopsy Devices Across Europe

 

NewswireToday - /newswire/ - London, United Kingdom, 2008/05/19 - The dramatic increase in the rate of cancer, coupled with the need for early detection, is driving the worldwide demand for biopsy devices.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In Europe, the market for biopsy devices is facing challenges such as fierce competition and lack of reimbursements. Despite the dominance of tier I participants, there is still a significant level of competition among smaller participants for market share.

New analysis from Frost & Sullivan (medicaldevices.frost.com), European Market for Biopsy Devices, finds that this market earned revenues of $213.8 million in 2007 and estimates this to reach $370.5 million in 2014.

"Increased public awareness, paralleled with the sharp rise in the incidence of cancer, is propelling the demand for biopsy devices, globally," notes Frost & Sullivan Research Analyst Janani Narasimhan. "These trends are rapidly broadening the scope of a previously underserved market, with biopsy devices set to experience significant growth in the coming years."

Technology continues to play an important role in this market. It is increasingly being used to avoid surgical procedures and enhance treatment regimes in conjunction with patient monitoring capabilities.

However, many countries in Europe do not offer reimbursement for biopsy devices such as core needles. Many insurance companies still consider biopsies as investigation techniques. Consequently, reimbursement is denied unless physicians can demonstrate that the procedure was medically necessary and unavoidable. The lack of adequate reimbursement streams will pose a hurdle for companies wishing to increase their unit sales and market revenues.

"Moreover, the highly concentrated market is heightening the barriers to entry, with large market shares being controlled by major market participants such as CR Bard, Cardinal Health Inc. and Ethicon Endo-Surgery Inc.," adds Narasimhan. "It is, therefore, important for companies with smaller market shares to strategically forge alliances with other market participants."

Smaller market participants should form alliances with companies that can help them increase sales and subsequently, market share. By forging alliances, smaller companies can actively participate and compete with more well-established market participants.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the European market for biopsy devices, then send an email to Patrick Cairns, Corporate Communications, at pcairns_pr[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.

European Market for Biopsy Devices is part of the Medical Devices Growth Partnership Services Programme, which also includes research in the following markets: European Bone Growth and Spinal Fusion Stimulators, European Bone Grafts and Bone Cements and European Urinary Incontinency. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

European Market for Biopsy Devices
M1AE

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Rising Incidence of Cancer Promotes Uptake of Biopsy Devices Across Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Patrick Cairns 
+27 18 468 2315 patrick.cairns[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55.0 Mn by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA
AFC Industries Joins HIMSS for its 56th Edition
Medical Companies Flock to Israel for R&D Support Infrastructure and Inorganic Growth Opportunities Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)